Why India’s biopharma value shift could unlock an additional $125-bn opportunity
What are the broad global consumer health trends driving the global biopharma sector this decade?
We believe that global…
Author
Why weight loss cannot be an aesthetic goal
How has the launch of GLP-1 medication disrupted weight loss/obesity care models globally?
For a long time, obesity care was…
India is one of Zoetis’ strongest markets in Asia for in-ovo vaccination
The recent H5N1 avian influenza resurgence in poultry farms in certain districts of Maharashtra and Karnataka once again reminds…
The fine line between reform and risk
A couple of recent notifications, one a notified amendment and the second one, a proposed amendment, concerning medicines have…
Financial strategies for uncertain times
Inspite of current geopolitical disruptions,both larger pharma enterprises and smaller promoter-driven entities are playing for…
India is well on its path to strongly push back the perception battle of quality
As we mark International Clinical Trial Day today, Dr Seema Pai, President, ISCR explains to Viveka Roychowdhury why it is…
JNPC: Carrying forward a 20-year old legacy
Billed as India’s first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private…
Sun Pharma bets on Organon for its next wind
Sun Pharma’s $12 billion acquisition of Organon will prove to be a milestone as the largest takeover by an Indian pharma company.…
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover…
Mumbai Experience Center reflects Agilent’s continued commitment to India
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…